Clipper Young

Dr. Clipper Young


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Diabetes Spectrum
Verified
Journal Article
Closed access
PDF file
CYClipper Young
Clipper Young
MMMarianne Moussa
Marianne Moussa
jay H shubrookjay H shubrook
jay H shubrook

1 August 2019 in Diabetes Spectrum
Verified
Journal Article
Open access
PDF file
CYClipper Young
Clipper Young
JCJinjing Cheng
Jinjing Cheng
GMGordon McCarter
Gordon McCarter
The purpose of this pilot study was to assess the associations between diabetes-related distress and predicted 10-year risks for cardiovascular complications in a lower-socioeconomic-status population with type 2 diabetes. Diabetes-related distress was found to be significantly associated with the predicted 10-year risk for coronary heart disease in the studied population. In addition, the association between the predicted 10-year risk for stroke and diabetes-related distress was also statistically significant among individuals with lower occupational status scores. Based on these results, primary care providers are encouraged to integrate a psychosocial assessment into their clinical practices in diabetes management. Identification of diabetes-related distress might be an additional means to increase patient engagement in diabetes management and to help address patients’ risks of cardiovascular complications, especially in safety-net clinics serving socioeconomically disadvantaged populations.

27 August 2020 in Journal of Osteopathic Medicine
Verified
Journal Article
Closed access
PDF file
CYClipper Young
Clipper Young
JSJay H. Shubrook
Jay H. Shubrook
EVElyssa Valencerina
Elyssa Valencerina
SWShirley Wong
Shirley Wong
SLSze Ngong Henry Lo
Sze Ngong Henry Lo
JDJoy A. Dugan
Joy A. Dugan
Context: Diabetes is a complex, chronic condition and managing it can have psychosocial implications for patients, including an impact on relationships with their loved ones and physical wellness. The necessary modifications to daily behaviors can be very overwhelming, thus leading to diabetes-related distress. Objective: To investigate the association between diabetes-related distress and perceived social support among people with type 2 diabetes. Methods: This cross-sectional study surveyed a population with a lower socioeconomic status (Medi-Cal recipients, which are only given to low-income individuals) in Solano County, California. Patients who had type 2 diabetes mellitus, who were between 40 and 80 years old, and who had a medical appointment in the clinic(s) at least once between December 2015 and December 2016 were included. Patients who could not understand or speak English and patients whose primary care clinicians declined their participation in the study were excluded from the study. Each study participant was recruited at the end of their medical appointment, and the survey instrument in paper form was administered. The Problem Areas in Diabetes (PAID) scale, which indicates diabetes-related distress, and Multidimensional Scale of Perceived Social Support (MSPSS) with 3 subscales (family, friends, and significant others) were used in this study. Multiple linear regression models were used to analyze the associations between PAID and MSPSS surveys. Results: For the 101 participants included in our study, multiple linear regression models showed statistically significant association between total MSPSS scores and total PAID scores (β = −.318; 95% CI, .577, −.0581; P=.017) as well as between MSPSS family subscale scores and total PAID scores (β= −.761; 95% CI, −1.35, −.168; P=.012). Among the 3 MSPSS subscales, higher perceived support from family members was found to be significantly associated with lower total PAID scores (β= −.761; 95% CI, −1.35, −.168; P=.012). Conclusion: Our findings suggest that a higher level of perceived social support experienced was associated with lower diabetes-related distress among patients with type 2 diabetes. Osteopathic physicians have a central role in providing comprehensive, patient-centered, holistic care, and the attention to social support in chronic disease management can help remove barriers in providing optimal care.

13 December 2021 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
DMDiya Manavalan
Diya Manavalan
CSCasey Shubrook
Casey Shubrook
CYClipper Young
Clipper Young

22 February 2022 in Journal of Osteopathic Medicine
Verified
Journal Article
Open access
PDF file
CYClipper Young
Clipper Young
RMRachael Mullin
Rachael Mullin
JMJoy A. Moverley
Joy A. Moverley
JSJay H. Shubrook
Jay H. Shubrook
Context: Diabetes-related distress (DRD) is experienced by nearly 50% of people with diabetes at any given time in their diagnosis. The effects of low socioeconomic status (SES) and lacking access to resources can increase DRD. In addition, cardiovascular (CV) complications associated with diabetes are associated with higher DRD scores. Objectives: This study evaluated the associations between DRD and predicted CV risks in participants with type 2 diabetes. Methods: This cross-sectional study included 234 individuals with low SES who were Medi-Cal (California version of Medicaid) beneficiaries and sought medical care at a safety-net clinic system. The Problem Areas in Diabetes (PAID) questionnaire assessed DRD levels. The United Kingdom Prospective Diabetes Study Risk Engine was utilized to predict 10-year risks for coronary heart disease (CHD), fatal CHD, stroke, and fatal stroke. A multivariate linear regression model was constructed between the two variables, including other variables to control for potential confounding factors, for assessing the associations. Results: After controlling for potential confounders, participants’ total PAID questionnaire scores were significantly associated with their 10-year predicted fatal CHD risks (B=0.060, 95% CI: [0.00084, 0.12], p=0.047). Conclusions: After controlling for covariates, DRD levels exhibited a significant association with increased 10-year predicted fatal CHD risks in patients with type 2 diabetes and lower SES. Screening for DRD and provision of appropriate psychosocial interventions may reduce the risks of CHD in those with type 2 diabetes.

4 September 2023 in Endocrines
Verified
Journal Article
Open access
PDF file
CYClipper Young
Clipper Young
NFNeeka Farnoudi
Neeka Farnoudi
JCJenny Chen
Jenny Chen
jay H shubrookjay H shubrook
jay H shubrook
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were once known as a class of glycemic-lowering agents to treat type 2 diabetes. As the evolving evidence from recent cardiorenal trials on these agents has shown—e.g., EMPA-REG OUTCOME, DECLARE-TIMI 58, CANVAS Program, DAPA-CKD—disclosing their benefits beyond glycemic management, SGLT-2 inhibitors have stimulated a shift in the management of T2DM and its comorbidities, specifically preventing cardiovascular events in people with ASCVD, preventing heart failure hospitalizations, and delaying the progression of chronic kidney disease. As a result, their usage beyond glycemic management has been included in clinical practice guidelines. Although SGLT-2 inhibitors have shown promising results in cardiorenal outcomes, patients have not had equal access to these agents, at least in the United States, suggesting a systemic issue of health inequity. This review article explores the mechanisms by which cardiorenal benefits are offered, the results of the landmark clinical trials for these agents, and their place in therapy.